Guidance

Diabetic eye screening: optical coherence tomography in surveillance

Guidance for diabetic eye screening providers on use of optical coherence tomography (OCT) in surveillance clinics.

From:
PublicNHS Health England
Published
8 July 2020
Last updated
1027 JulySeptember 2024 — See all updates

Applies to England

Documents

Optical coherence tomography (OCT) in diabetic eye screening (DES) surveillance clinics

Ref: PHE publications gateway number GW-1385

HTML

Optical coherence tomography (OCT) in diabetic eye screening (DES) surveillance clinics - Starting 1 October

HTML

OCT examples

Ref: PHE publications gateway number GW-1385

HTML

Diabetic eye screening: OCT in surveillance pathway

Ref: PHE publications gateway number GW-1385

HTML

Details

This document provides consistent best practice guidance for diabetic eye screening (DES) services on the management of diabetic maculopathy in digital surveillance (DS) clinics using optical coherence tomography (OCT).

ContactThis thepublication PHEwas Screeningpreviously helpdeskpublished withby anyPublic queriesHealth aboutEngland, thiswhich publication,closed makingon sure30 youSeptember include its full title.2021.

Updates to this page

Published 8 July 2020
Last updated 1027 JulySeptember 2024 + show all updates

  1. Added clarification that publication was previously published by Public Health England.

  2. Removed PHE

  3. Updated guidance

  4. First published.

Sign up for emails or print this page